Search Results (441)

Background/Objectives: Tallaga cheese is an artisanal form of traditional Egyptian soft white Damietta cheese, characterized by high moisture, elevated salinity, and a limited shelf life, which collectively increase its vulnerability to microbial contamination. Typically produced from raw or minimally heated cow or buffalo milk, Tallaga cheese represents a relevant model for studying emerging food safety challenges. Methods/Results: This study revealed marked variability among commercial samples and, unexpectedly, a general absence of typical lactic acid bacteria (LAB) such as Lactococcus spp. Instead, enterococci, microorganisms increasingly associated with antimicrobial resistance and virulence traits, emerged as the dominant LAB group, with the detection of Enterococcus faecium strains posing particular concern for dairy safety. To address these challenges, the antimicrobial potential of isolated LAB was evaluated against Latilactobacillus sakei (CECT 906). Twelve bacteriocin-producing strains were identified: ten Enterococcus faecalis, one E. faecium, and one Lactococcus lactis. Enterococci demonstrated robust tolerance to stress conditions, including high salt concentrations, emphasizing their persistence in dairy environments. Given the relevance of controlling resistant and potentially virulent strains such as E. faecium, the bioprotective capacity of two bacteriocinogenic L. lactis strains (IPLA 1064 and AHRI ST9) was assessed using a laboratory-scale cheese model. Both strains effectively inhibited E. faecium AHRI CH4, achieving reductions of 2.6 and 3.6 log units (99.9%). Conclusions: These findings underscore the relevance of bacteriocin-producing L. lactis as natural biopreservatives to mitigate emerging threats related to antimicrobial-resistant food-borne pathogens in dairy products. Full article

Microbial contamination of food is a crucial cause of food spoilage and foodborne diseases, posing a severe threat to global public health. Although chemical preservatives are effective, their potential hazards to human health and the environment, coupled with the growing demand for “clean label” products, have driven the search for natural alternatives. Lactic acid bacteria (LAB), recognized as the Generally Recognized as Safe (GRAS) microorganisms, have emerged as the promising bio-preservatives due to their safety, effectiveness, and multifunctionality. This review systematically summarized the core antimicrobial properties of LAB, including their inhibitory spectrum against foodborne pathogens, spoilage microorganisms, viruses, parasites, and their ability to degrade toxic substances such as mycotoxins, pesticides, and heavy metals. Key inhibitory mechanisms of LAB are highlighted, encompassing the production of antimicrobial metabolites, leading to metabolism disruption and cell membrane damage, nutrition and niche competition, quorum-sensing interference, and anti-biofilm formation. Furthermore, recent advances in LAB applications in preserving various food matrices (meat, dairy products, fruits and vegetables, cereals) are integrated, including their roles in enhancing food sensory quality, extending shelf life, and retaining nutritional value. The review also discusses critical factors influencing LAB’s inhibitory activity (medium composition, culture conditions, ionic components, pathway regulator, etc.) and the challenges associated with the application of LAB. Finally, future research directions are outlined, including the novel LAB and metabolites exploration, AI-driven cultural condition optimization, genetic engineering application, nano-encapsulation and active packaging development, and building up the LAB-based cellular factories. In conclusion, LAB and their antimicrobial metabolites hold great promise as green and safe food preservatives. This review is to provide comprehensive theoretical support for the rational improvement and efficient application of LAB-based natural food preservatives, contributing to the development of a safer and more sustainable food processing and preservation systems. Full article

Ozone micro–nano bubbles (OMNBs) are an emerging preservation technology. However, there are few reports regarding their application in controlling postharvest diseases of agricultural products. Radix astragali, as a medicinal and edible plant, is particularly vulnerable to pathogenic microorganisms during postharvest storage, which leads to diminishing the quality and commercial value. In this study, fresh R. astragali inoculated with Penicillium polonicum was treated with different concentrations (2, 3, 4, 5, 6, 8 mg/L) of OMNBs and stored at room temperature for 28 days. The results indicate that 3 mg/L OMNBs application for 8 min effectively inhibited the development of blue mold in fresh R. astragali and preserved its quality. Then, we compared the three different treatments of micro–nano bubbles (MNBs), 3 mg/L O₃, and 3 mg/L OMNBs on physiological and pathological parameters of un-inoculated fresh R. astragali during storage and analyzed the changes in the active ingredients by liquid chromatography and metabolomics. The results indicate that the 3 mg/L OMNBs treatment effectively inhibited the decline in weight loss rate, respiratory rate, firmness, browning index, and ABTS and DPPH radical-scavenging rates, as well as reduced the incidence rate and disease index of fresh R. astragali during storage. The metabolomics results suggest that the 3 mg/L OMNBs application activated the mevalonate pathway (MVA), the methylerythritol phosphate pathway (MEP), and the phenylpropanoid biosynthesis pathway to maintain the content of active ingredients such as terpenoids and flavonoids, and these findings are consistent with the results of HPLC-MS analysis. Full article

Foodborne diseases remain a major global challenge because pathogenic microorganisms persist in food systems, often protected by biofilms and increasing resistance to conventional chemical preservatives and sanitizers. Control strategies that were effective in the past are becoming less reliable in complex processing environments, creating a need for more precise and adaptable food-safety approaches. This review examines emerging technologies that shift food safety from broad, reactive control toward targeted, data-driven intervention. Biological tools, including bacteriophages, phage-derived enzymes, bacteriocins, quorum-sensing inhibitors, and gene-guided antimicrobial systems, are discussed for their capacity to selectively control specific pathogens while limiting unintended effects on beneficial microbiota. The review also addresses nano-enabled strategies that improve antimicrobial stability, delivery, and performance, along with plant-derived and microbial bioactive compounds that support clean-label and sustainable preservation. In parallel, advances in anti-biofilm surface engineering, such as nano-textured, contact-active, and responsive materials, are examined as preventive measures to reduce microbial attachment and persistence on food-contact surfaces. Beyond individual interventions, this review emphasizes integration within coordinated multi-hurdle systems supported by real-time monitoring and predictive analytics. Emerging digital frameworks, including digital twins of food-processing lines, are highlighted as tools to link detection, risk prediction, and targeted control. Finally, remaining knowledge gaps, regulatory challenges, and research priorities are identified, highlighting the need for realistic testing, long-term safety evaluation, standardized validation, and collaborative efforts to translate precision food-safety technologies into dependable real-world applications. Full article

The extensive and often inappropriate use of antibiotics has led to the rapid emergence and spread of antibiotic resistance, reducing their effectiveness against pathogenic microorganisms. Fosfomycin has become an increasingly important therapeutic option in both human and veterinary medicine, particularly when other antibiotics fail. This review summarises current knowledge on the occurrence of fosfomycin resistance and evaluates the role of agricultural practices in its dissemination. Multiple microbial resistance mechanisms have been identified, including genes from the fosA, fosB, and fosC families, and new determinants continue to be reported. Agriculture contributes to the environmental spread of resistance through the use of antibiotics in food-producing animals, the exchange of resistant microorganisms between humans and animals, and the application of manure as fertiliser. Fosfomycin resistance genes have been detected in livestock such as pigs, chickens, pigeons, and cows, as well as in vegetables. Their presence in soil is influenced by fertilisation, nitrogen levels, microplastics, heavy metals, and pesticide application. Additionally, climate warming may facilitate the broader dissemination of fosfomycin resistance. Despite increasing evidence, current understanding remains limited. Further research is needed to elucidate the mechanisms driving the spread of fosfomycin resistance in agricultural environments and to develop effective monitoring strategies. Full article

Postbiotics, which are preparations of inanimate microorganisms and their components, have emerged as a promising functional ingredient in animal health and nutrition. Postbiotics are primarily composed of microbial cell fractions, metabolites, enzymes, vitamins, polysaccharides, and short-chain fatty acids. Unlike probiotics, postbiotics do not contain live microorganisms, which strengthens their greater stability and safety in feed/food formulations. Postbiotics offer several beneficial effects, including antioxidant, anti-inflammatory, immune-modulatory, and antimicrobial actions. They enhance antioxidant enzymes, neutralize reactive oxygen species, and inhibit lipid peroxidation, thereby protecting tissues from oxidative damage. Postbiotics also inhibit pro-inflammatory molecules like TNF-α and IL-6, while enhancing the anti-inflammatory cytokine IL-10, promoting the maturation and function of immune cells, and increasing secretory IgA production. They suppress a variety of pathogenic bacteria, including Escherichia coli, Salmonella, Staphylococcus, Campylobacter, etc., both in vitro and in vivo. Moreover, they increase beneficial gut bacteria and improve the digestion and integrity of the intestine. This article outlines the beneficial effects of postbiotics in animals including poultry, swine, canine, feline, horses, and ruminant animals, either as feed/food or as a supplement. The integration of postbiotics into animal feed improves growth performance, feed conversion ratios, and disease resistance in animals. Thus, the multifunctional benefits of postbiotics make them a valuable tool for healthy companion animals and sustainable livestock production, supporting both animal welfare and productivity without the drawbacks associated with antibiotic growth promoters. Full article

Colorectal cancer (CRC) represents a significant global health burden, ranking as the third most frequently diagnosed malignancy worldwide. Emerging evidence has established a compelling association between gut microbiota dysbiosis and CRC pathogenesis, revealing complex mechanisms through which specific bacterial communities modulate carcinogenesis. This comprehensive review synthesizes current knowledge on the mechanistic contributions of gut microbiota to CRC development, with particular emphasis on key pathogenic bacteria including Fusobacterium nucleatum, Bacteroides fragilis, and Escherichia coli. We examine the molecular pathways through which these microorganisms promote tumorigenesis, including chronic inflammation induction, immune response modulation, metabolic reprogramming, and direct genotoxic effects. Furthermore, we discuss the therapeutic implications of microbiota-targeted interventions and the potential utility of microbial biomarkers for early CRC detection. Understanding the intricate host–microbiota interactions in CRC pathogenesis may facilitate the development of novel preventive strategies and therapeutic approaches for this devastating disease. Full article

The poultry industry plays a major role in the emergence and spread of foodborne zoonotic diseases, particularly those associated with antibiotic-resistant bacteria. These diseases pose substantial global public health challenges, and the increasing development of antimicrobial resistance further intensifies these concerns. In response, scientific efforts have expanded to develop and implement innovative technologies capable of mitigating the rising prevalence of multidrug-resistant (MDR) microorganisms. Therapeutic bacteriophage supplementation has regained significant attention because it can selectively lyse specific bacteria, is cost-effective to produce, offers environmentally favorable characteristics, and provides several advantages over conventional antibiotics. Experimental studies have demonstrated that phage therapy is both safe and effective for controlling poultry-associated enteric pathogens. Phages can be applied at various stages of the poultry production chain, from rearing to processing and distribution, using multiple delivery strategies. Despite certain limitations, the targeted and well-regulated application of phage cocktails offers considerable potential as an alternative to antibiotics for managing MDR infections. The success of bacteriophage therapy depends on several factors, including the timing of administration, dosage, delivery method, and its integration with other therapeutic approaches. Therefore, developing a comprehensive understanding of bacteriophage utilization in poultry production is both timely and necessary. This review examines the applications, constraints, and future opportunities of phage therapy within the commercial poultry industry, with particular emphasis on the mechanisms through which bacteriophages control bacterial infections. Full article

Agricultural production is becoming increasingly difficult due to various environmental fluctuations brought on by climate change. Overall increase in atmospheric temperatures due to greenhouse gases, changing rainfall patterns leading to severe water shortages, and deforestation have led to many areas facing drought conditions, causing more stress for producing enough food crops to fulfil increasing global demand. This is also exacerbated by emerging phytopathogens causing severe disease outbreaks, making it difficult to control them without drastic measures. Excessive use of agrochemicals in these areas could lead to more ecological displacements and therefore, sustainable agricultural practices are required to avoid causing more harm. Microorganisms with climate-adaptive characteristics and qualities that would be helpful in acting as bioinoculants and biological control, could prove to be more successful in sustainably controlling emerging pathogens as well as improving the overall plant immunity and health in drought affected areas. We discuss how climate change driven changes in farming areas have made them vulnerable towards emerging pathogens, and highlight how biological control agents can be successfully utilized to possibly overcome this without causing more environmental damage. This review provides a background for future research by linking the climate adaptive characteristics of microorganisms with biocontrol and plant health improving capabilities and how they can effectively be used for eco-friendly agricultural practices in agroecosystems impacted by climate change. Full article

Hyaluronic acid (HA) is a ubiquitous glycosaminoglycan essential for maintaining tissue hydration, structural integrity, and immunological homeostasis in vertebrates. Although traditionally regarded as a host-derived molecule, HA is also produced by a range of microorganisms, most notably Streptococcus spp., through specialized hyaluronan synthases (HAS). Microbial HA and host-derived HA fragments play key roles not only in tissue physiology but also in infection biology, influencing microbial virulence, biofilm formation, and immune evasion. In bacteria, HA-rich capsules promote adhesion, shield pathogens from complement-mediated opsonization and phagocytosis, and facilitate dissemination through host tissues. Conversely, HA-degrading enzymes and reactive oxygen species generate low-molecular-weight HA fragments that amplify inflammation by activating—toll-like receptor 2 (TLR2)/toll-like receptor 4 (TLR4) signaling, contributing to chronic inflammatory states. Furthermore, microbial HA modulates biofilm organization in both bacterial and fungal pathogens, enhancing persistence and antimicrobial tolerance. Clinically, widespread use of HA-based dermal fillers has generated increasing concern over delayed biofilm-associated infections, diagnostic challenges, and complications arising from microbial contamination and host–microbe interactions. Recent advances in HA engineering, including anti-microbial HA conjugates and receptor-targeted biomaterials, offer promising strategies to mitigate infection risk while expanding therapeutic applications. This review synthesizes current knowledge on HA biosynthesis across biological kingdoms, its dualistic role in health and disease, and its emerging relevance at the interface of microbiology, immunology, and biomedical applications. Full article

Background and Objectives: Antimicrobial resistance is one of the most significant threats to modern healthcare, especially in intensive care units where ESKAPE pathogens—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.—account for the majority of healthcare-associated infections. Romania is among the European countries with the highest rates of antimicrobial consumption and resistance. This study aimed to describe the epidemiological trends and antimicrobial resistance profiles of ESKAPE isolates over a four-year period (2021–2024) in a Romanian ICU (Intensive Care Unit). Materials and Methods: We conducted a retrospective observational study of all microbiological samples collected from adult ICU patients at the Clinical Emergency County Hospital of Sibiu between 2021 and 2024. Data were extracted from the electronic laboratory system and included patient demographics, specimen types, isolated microorganisms, and antimicrobial resistance classifications. Statistical analyses were performed using Python libraries, with significance set at p < 0.05. Results: A total of 801 infections were recorded, of which 562 (70.2%) involved ESKAPE pathogens. The predominant organisms identified were Klebsiella pneumoniae (42.8%) and Acinetobacter baumannii (36.0%), followed by Pseudomonas aeruginosa (11.2%). Nearly half of the isolates (47.3%) were multidrug-resistant, and 22.3% were extensively drug-resistant. Respiratory specimens, particularly tracheal aspirates, accounted for the majority of the isolates and exhibited the highest proportion of resistant phenotypes. A significant temporal increase in extensively drug-resistant isolates was observed over the study period (p < 0.05). Conclusions: ESKAPE pathogens remain the leading causes of ICU infections in Romania, with Klebsiella pneumoniae and Acinetobacter baumannii contributing significantly to the burden of multidrug- and extensively drug-resistant infections. Strengthening infection prevention strategies, optimizing antimicrobial stewardship, and implementing continuous microbiological surveillance are essential to mitigate the evolving resistance crisis in Romanian critical care settings. Full article

Escherichia ruysiae is a recently characterized species within the Escherichia genus, often misclassified as E. coli due to limitations in existing operating procedures and diagnostic databases. In this study, we report the first isolation and genomic characterization of E. ruysiae in Togo, from a five-year-old female patient who was hospitalized with gastroenteritis and bloody diarrhea and subsequently died after eight days. Biochemical tests and MALDI-TOF initially identified the microorganism as E. coli, but phylogenomic and Average Nucleotide Identity (ANI) analysis confirmed it to be E. ruysiae, Clade IV with enteroaggregative associated genes. Whole genome sequencing of the strain FK53-34 enables the identification of resistance genes, including bla_EC-15, eptA, and pmrF. The virulence profile of the strain included, but was not limited to aap, aatABC, and senB genes, which may support its pathogenicity and virulence. Multilocus sequence typing (MLST) did not match any known sequence type, which is obvious for a newly characterized microorganism. This study highlights the critical need for enhanced diagnostic tools and surveillance systems to identify emerging pathogens, including Escherichia ruysiae. Full article

Companion animals, including dogs and cats, share close living environments with humans, making antimicrobial stewardship essential to prevent zoonotic transmission of resistant pathogens. The overuse and misuse of conventional antibiotics in veterinary medicine have accelerated the emergence of multidrug-resistant (MDR) microorganisms, prompting the need for alternative strategies. Natural compounds, such as antimicrobial peptides (AMPs), phytochemicals, chitosan-based polymers, and nutraceuticals, offer promising solutions due to their broad-spectrum activity, low resistance potential, and additional health-promoting properties. This review provides a comprehensive analysis of recent advances of the aforementioned compounds for companion animals, including their mechanisms of action, applications in feed and nutraceuticals, and therapeutic use in dermatological, gastrointestinal, and systemic infections. We discuss the current challenges related to bioavailability, safety, standardization, and regulatory frameworks, as well as future perspectives for integrating these agents into veterinary practice. Emphasis is placed on clinical evidence in dogs and cats, highlighting how natural antimicrobials can contribute to sustainable infection control and antimicrobial resistance mitigation under the One Health paradigm. Full article

Global agricultural production is challenging due to climate change and a number of phyto-pathogenic organisms and pests that pose a significant threat to both crop growth and productivity. The growing resistance of pests and diseases to synthetic chemicals makes crop production even more difficult, which highlights the urgent need for alternative solutions. From this perspective, marine microorganisms have emerged as a significant natural product source for their distinctive bioactive compounds and environmentally sustainable potential pesticidal activity. The unique microbial resources and structurally diverse metabolites of the marine ecosystem have been proven to have strong antagonistic effects against a broad spectrum of agricultural diseases and pests, making them a valuable candidate for the development of novel pesticides. This review highlights 126 marine natural products from marine microorganisms with diverse metabolic pathways and bioactivities against agricultural pests, pathogens, and weeds. The findings underscore the potential of marine-derived compounds in addressing the growing challenges of crop protection and offering an appealing strategy for future agrochemical research and development. Full article

Striped catfish, Pangasianodon hypophthalmus, has recently emerged as a promising candidate for Egyptian aquaculture owing to its rapid growth; however, under intensive culture, it is vulnerable to Aeromonas hydrophila. The efficacy of dietary supplementation with effective probiotic microorganisms (EPMs) in enhancing growth performance, feed utilization, physiological health, and disease resistance of P. hypophthalmus against A. hydrophila challenge was evaluated. A 90-day feeding trial was conducted with 300 fish randomly distributed into four triplicate groups (25 fish per replicate) reared in 12 indoor fiberglass tanks: a control and three groups receiving EPMs at inclusion levels of 1.5%, 3%, and 4.5%. The results showed significant, dose-dependent improvements across all EPMs-supplemented groups in survival, growth rates, feed utilization, and hematological parameters (RBC, Hb, PCV, WBC, and lymphocytes). Dietary EPMs led to significant improvements (p ≤ 0.001) in digestive efficiency, protein and lipid metabolism, antioxidant enzyme activity, immune performance, and the ability of striped catfish to withstand A. hydrophila infection. Hepatobiliary enzyme activities (ALT, AST, and ALKP), glucose levels, lipid profile markers, and hepatic MDA exhibited a significant linear decrease (p ≤ 0.0001) with increasing EPMs levels. The gut microbial composition showed a dose-dependent increase in beneficial lactic acid bacteria (LAB) and a reduction in TAPC, pathogenic coliforms (TFCC), and Vibrio spp. (TVC). These results demonstrate the dose-dependent effects of EPMs on enhancing aquafeed efficiency, overall health, and innate immunity in striped catfish. Full article